ASX:API Australian Pharmaceutical Industries (API) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Australian Pharmaceutical Industries Stock (ASX:API) 30 days 90 days 365 days Advanced Chart Get API alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume453,647 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield2.29%Price TargetN/AConsensus RatingN/A Company Overview Australian Pharmaceutical Industries Limited engages in the wholesale distribution of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies primarily in Australia. It also retails health and beauty products to consumers through a network of Priceline and Priceline Pharmacy franchise stores, and company owned Priceline stores in Australia; sells beauty products through Clear Skincare network of clinics in Australia and New Zealand; and manufactures and distributes pharmaceutical and toiletry goods to New Zealand, Australian, and Asian markets, as well as provides cosmetic products and non-invasive aesthetic beauty services. The company was founded in 1910 and is based in Camberwell, Australia. Read More Receive API Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Australian Pharmaceutical Industries and its competitors with MarketBeat's FREE daily newsletter. Email Address API Stock News HeadlinesTrump has flagged 200% tariffs on Australian pharmaceuticals. What do we produce here, and what’s at risk?July 11, 2025 | msn.comAustralia 'urgently seeking' details on Trump drug tariff planJuly 9, 2025 | msn.comMissed the Run So Far? This Is Your Second ChanceAccording to history, the final stretch of the crypto cycle is here — and this short window is where fortunes are made. Inside The Crypto Code Workshop, two experts reveal how to get positioned early, lock in profits, and access their top altcoin picks before the crowd. All attendees receive $10 in free Bitcoin just for showing up.July 18 at 2:00 AM | Crypto Swap Profits (Ad)Chemist Warehouse price rise warning after $8.8 billon deal greenlit: 'We will rue this day'November 7, 2024 | nz.finance.yahoo.comACCC clears Chemist Warehouse and Sigma’s $8.8b mega dealNovember 6, 2024 | msn.comNasdaq Wrap: Reddit notches first ever profit; while an Aussie company leads Nasdaq’s winnersNovember 6, 2024 | msn.comCaliway Completed CBL-514 Phase 2b Study (CBL-0205) for Subcutaneous Fat ReductionOctober 24, 2024 | finance.yahoo.comElon Musk's xAI launched its own APIOctober 22, 2024 | msn.comSee More Headlines API Stock Analysis - Frequently Asked Questions How were Australian Pharmaceutical Industries' earnings last quarter? Australian Pharmaceutical Industries Limited (ASX:API) released its quarterly earnings data on Wednesday, April, 17th. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.05 by $0.00. What other stocks do shareholders of Australian Pharmaceutical Industries own? Based on aggregate information from My MarketBeat watchlists, some other companies that Australian Pharmaceutical Industries investors own include Capricorn Metals (CMM), Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY), Global X Cloud Computing ETF (CLOU) and Downer EDI (DOW). Company Calendar Last Earnings4/17/2019Today7/18/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorBusiness Services Industry Medical Equipment Wholesale Sub-IndustryComputer Software Current SymbolASX:API CIKN/A Webwww.api.net.au Phone+61-3-88553000FaxN/AEmployees1,310Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth1.28Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio71.32 Current Ratio1.20 Quick Ratio0.77 Sales & Book Value Annual SalesA$4.00 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow8.26 Book ValueA$0.89 per share Price / BookN/AMiscellaneous Outstanding Shares492,656,000Free FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (ASX:API) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredFREE BUY ALERT: These 3 tiny AI stocks could surgeWe're living in unprecedented times. Most people think it's too late to get into AI right now … That the...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Australian Pharmaceutical Industries Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Australian Pharmaceutical Industries With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.